Ionizing radiation is a well-known risk factor for thyroid cancer in human populations. Chromosomal rearrangements involving the RET gene, known as RET/PTC, are prevalent in thyroid papillary carcinomas from patients with radiation history. We studied the generation of RET/PTC in HTori-3 immortalized human thyroid cells exposed to a range of doses of gamma-radiation and harvested 2, 5-6, and 9 d later. RET/PTC1 and RET/PTC3 were detected by RT-PCR followed by Southern blotting and hybridization with internal oligonucleotide probes. No RET/PTC was found in cells harvested 2 and 5-6 d after irradiation, whereas 59 RET/PTC events were detected in cells collected 9 d after exposure. The average rate of RET/PTC induction was 0.1 x 10(-6) after e...
A sharp increase in the incidence of pediatric thyroid papillary cancer was documented after the Che...
Background: Papillary thyroid carcinoma (PTC) is frequently associated with a RET gene rearrangement...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Pap...
Exposure to ionizing radiation is a well-known risk factor for a number of human cancers, including ...
Radiation etiology is well known in thyroid carcinogenesis. Ret rearrangement is the commonest oncog...
Rearrangements of the RET proto-oncogene may occur in both naturally occurring and radiation-induced...
Human chromosomal fragile sites are regions of the genome that are prone to DNA breakage, and are cl...
INTRODUCTION Papillary thyroid carcinoma (PTC) originates from follicular cells of thyroid gland an...
Two main types of RET/PTC oncogene, named RET/ PTC-1 and 3, occur in papillary thyroid carcinomas es...
Since the Chernobyl nuclear reactor accident, a striking increase of thyroid carcinoma has been repo...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
Background: Activation of the RET proto-oncogene, located on the long arms of chromosome 10, contrib...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
A sharp increase in the incidence of pediatric thyroid papillary cancer was documented after the Che...
Background: Papillary thyroid carcinoma (PTC) is frequently associated with a RET gene rearrangement...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...
Thyroid carcinoma is the most frequent endocrine cancer accounting for 5-10% of thyroid nodules. Pap...
Exposure to ionizing radiation is a well-known risk factor for a number of human cancers, including ...
Radiation etiology is well known in thyroid carcinogenesis. Ret rearrangement is the commonest oncog...
Rearrangements of the RET proto-oncogene may occur in both naturally occurring and radiation-induced...
Human chromosomal fragile sites are regions of the genome that are prone to DNA breakage, and are cl...
INTRODUCTION Papillary thyroid carcinoma (PTC) originates from follicular cells of thyroid gland an...
Two main types of RET/PTC oncogene, named RET/ PTC-1 and 3, occur in papillary thyroid carcinomas es...
Since the Chernobyl nuclear reactor accident, a striking increase of thyroid carcinoma has been repo...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
Background: Activation of the RET proto-oncogene, located on the long arms of chromosome 10, contrib...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
Structural chromosome aberrations are known hallmarks of many solid tumors. In the papillary form of...
A sharp increase in the incidence of pediatric thyroid papillary cancer was documented after the Che...
Background: Papillary thyroid carcinoma (PTC) is frequently associated with a RET gene rearrangement...
The rearranged during transfection (RET) proto-oncogene was identified in 1985 and, very soon therea...